RIUG:LSE:LSE-L&G US ESG Exclusions Paris Aligned UCITS ETF GBP (GBX)

ETF | Others |

Last Closing

USD 1520.4

Change

-30.40 (-1.96)%

Market Cap

USD 0.18B

Volume

700.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-0.13 (-0.05%)

USD 292,109.69B
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

-20.50 (-0.11%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+2.75 (+1.42%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.22 (-1.20%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.22 (-1.55%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

+1.37 (+1.27%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.37 (-1.21%)

USD 260.39B
0QZO:LSE 0QZO

-4.20 (-4.09%)

USD 258.54B

ETFs Containing RIUG:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.40% 13% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.40% 13% F 21% F
Trailing 12 Months  
Capital Gain 7.53% 70% C- 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.53% 67% D+ 64% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 13.35% 73% C 74% C
Dividend Return 13.35% 72% C 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.46% 58% F 74% C
Risk Adjusted Return 107.18% 91% A- 95% A
Market Capitalization 0.18B 58% F 33% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike